Wilms' tumor, or nephroblastoma, is a developmental malignancy of the
kidney that affects approximately 1 in 10,000 children between 1 and 6
years of age. Typically, the histology of nephroblastoma reveals a di
sorganized renal developmental process showing blastema and epithelia
randomly interspersed in varying amounts of stroma. This developmental
disruption is associated with the loss of function of the tumor suppr
essor gene WT-1. This gene, located on chromosome 11 at band p13, code
s for a zinc finger protein that may act as a transcriptional represso
r. Familial cases of Wilms' tumor fit Knudson's ''two hit'' model, acc
ording to which a germ line mutation of one WT-1 allele predisposes to
the tumor while an additional somatic mutation of the other allele ca
uses malignant transformation. Originally proposed for retinoblastoma,
this model defines the nature of the tumor suppressor gene as a gene
that is tumorigenic when inactivated. However, not all Wilms' tumor ca
ses fit this model because the majority of Wilms' tumors do not show a
mutation of WT-1. For Wilms' tumor, the loss of tumor suppression app
ears to be more complex than for retinoblastoma. Some of the mechanism
s recognized to date involve dominant negative WT-1 mutations, interac
tion of the WT-1 gene product with other mutated transcription factors
such as p53, loss of imprinting, and mutations of other tumor suppres
sor genes at 11p15 or other loci. Although classic Wilms' tumor is ass
ociated with good prognosis (85% survival), its anaplastic form is oft
en fatal. Despite the plethora of knowledge gained in recent years, Wi
lms' tumor remains the center of attention for further investigation b
ecause it offers opportunities for studying normal kidney development,
for understanding the molecular basis for clinically important anapla
stic forms, as well as for elucidating the molecular mechanisms of tum
or suppressor genes. To facilitate this task, Wilms' tumor heterotrans
plants have been established in nude mice. This provides an indefinite
source of tumor tissue and a means to test their growth properties in
response to drug treatments or molecular genetic manipulations. Furth
ermore, the establishment of stable Wilms' tumor cell lines is essenti
al to investigating further the molecular basis of tumorigenesis using
recombinant DNA technology. Copyright (C) 1994 by W.B. Saunders Compa
ny